コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 llular loop region that it has been shown to photolabel.
2 elective general anesthetic and an effective photolabel.
3 d state) and then rapidly frozen (<1 ms) and photolabeled.
4 contribute to the pool's architecture can be photolabeled.
5 roactive steroids inhibited etomidate analog photolabeling.
6 istance (CQR) affect the efficiency of AzBCQ photolabeling.
7 effect of phencyclidine (PCP) on [(125)I]TID photolabeling.
8 cid residues of the receptor for [125I]IACoc photolabeling.
9 Rs) were studied using electrophysiology and photolabeling.
10 , and top-down MS confirmed a single site of photolabeling.
11 and indinavir effectively protected against photolabeling.
12 econds after mixing, by use of time-resolved photolabeling.
13 ulator, which neither enhanced nor inhibited photolabeling.
16 yrrolidinediol (8-N(3)-ADP-HPD), was used to photolabel a recombinant bovine PARG catalytic fragment
19 ta-tubulin and [(3)H]2-(m-azidobenzoyl)Taxol photolabels a peptide containing amino acid residues 217
21 rified alpha4beta2 nAChRs, [(3)H]epibatidine photolabeled alpha4Tyr(195) (equivalent to Torpedo alpha
22 a site at the gamma-alpha subunit interface, photolabeling alphaM2-10 (alphaSer-252) and gammaMet-295
24 brane domain outside the ion channel, but it photolabels alphaMet-386 and alphaSer-393 in the cytopla
25 tylcholine binding sites, [(3)H]azietomidate photolabeled alphaTyr-93, alphaTyr-190, and alphaTyr-198
26 t sites within the alpha and delta subunits, photolabeling alphaVal-218 (alphaM1), deltaPhe-232 (delt
31 determined by Edman degradation some of the photolabeled amino acids in nAChR subunit fragments isol
33 In the presence of agonist, [(3)H]dFBr also photolabeled amino acids in the nAChR extracellular doma
35 nce of agonist (carbamylcholine), both drugs photolabeled amino acids on the complementary (non-alpha
37 nds at the extracellular end of the channel, photolabeling amino acids at positions M2-16 (alpha,gamm
38 n gammaM3, and to a site in the ion channel, photolabeling amino acids within each subunit M2 helix t
39 ilize the nAChR in a closed state, [(3)H]CPZ photolabels amino acids at M2-5 (alpha), M2-6 (alpha,bet
41 a-tubulin isotypes, bovine brain tubulin was photolabeled and the isotypes resolved by high-resolutio
42 d mitochondria, individual mitochondria were photolabeled and tracked through fusion and fission.
43 he pivotal reactive intermediate involved in photolabeling and cross-linking studies using the 8-azid
44 gA in DMPC bilayers, direct [(14)C]halothane photolabeling and microsequencing demonstrated dominant
46 oflurane binding sites were identified using photolabeling and were further validated by the docking
47 hR binding moiety, a benzophenone moiety for photolabeling, and an alkyne moiety for biotinylation vi
48 differential scanning calorimetry and lipid photolabeling, and measured the affinity of this interac
49 ,1'-binaphthyl-5,5'-disulfonic acid (BisANS) photolabeling approach to monitor changes in protein unf
51 nd subunit selectivity of [(3)H]azietomidate photolabeling are discussed in terms of the structures o
52 ids enhance rather than inhibit azietomidate photolabeling, as assayed at the level of GABA(A)R subun
56 oreover, the PS1 heterodimer is specifically photolabeled at the cell surface by a potent inhibitor t
59 fen, whereas neither drug inhibits [(3)H]CPZ photolabeling at the extracellular end, establishing tha
61 and that [(3)H]azidopine can also be used to photolabel both wild-type R482-ABCG2 and mutant T482-ABC
63 3 and alpha1Met-236 in alpha1M1), previously photolabeled by [(3)H]azietomidate, and alpha1Ile-239, l
65 ino acids of each nAChR subunit specifically photolabeled by [(3)H]tetracaine that contribute to the
67 olated, detergent-solubilized GluT1.HA.H6 is photolabeled by [gamma-32P]-azidoATP in an ATP-protectab
69 des (or limited sequences) site-specifically photolabeled by radioactive photolabile oligoDNA probes
70 rface involving gammaTrp-453 (M4), a residue photolabeled by small lipophilic probes and promegestone
75 mer-causing mutation in PS1 strongly reduced photolabeling by a transition-state analogue but not by
76 ncentration dependence of inhibition of that photolabeling by etomidate or R-mTFD-MPAB also establish
77 tates by using electrophysiology-coordinated photolabeling by several lipophilic probes followed by m
79 dines are substrates of ABCG2 and that these photolabels can be used to screen new substrates and/or
81 a32P]ATP-nucleotidylated or [alpha32P]8N3ATP-photolabeled CK is treated with trypsin a single, identi
86 (3)) resulted in complete protection against photolabeling, demonstrating that [(32)P]pApAp(8-azidoA)
87 had normal ATPase activity, indicating that photolabeling did not significantly alter the enzymatic
88 t that the ability of NANTP and SSL-NANTP to photolabel different sites results from different orient
89 mately 0.5 mol of (14)C/mol of subunit, with photolabeling distributed within the nAChR extracellular
91 er-free radioiodinated [125I]IAS was used to photolabel epitope-tagged human beta 2AR in membranes pr
93 l-terminal fourth repeat of annexin from the photolabeling experiment using domain-deletion mutants o
94 ion kinetics, photoinactivation studies, and photolabeling experiments are also included; these exper
105 nt stereospecific barbiturate anesthetic, to photolabel expressed human alpha1beta3gamma2 GABAARs.
110 analogue photolabeling reagents in which the photolabeling groups were placed at three positions arou
111 rescent groups for the purpose of performing photolabeling have been prepared and evaluated using the
114 nalogue, 16b, was radioiodinated and used to photolabel human DAT-transfected HEK 293 cell membranes.
115 binding sites in an extrasynaptic GABAAR, we photolabeled human alpha4beta3delta GABAARs purified in
118 orms of RNase L has been completed utilizing photolabeling/immunoprecipitation and affinity assays, r
119 7, followed by thrombin digestion, retained photolabel in a 22-kDa fragment, indicating that iodoami
120 ace; the etomidate analog [(3)H]azietomidate photolabeled in a pharmacologically specific manner two
122 (alphaGlu-390, alphaCys-412) that were also photolabeled in nAChRs in the equilibrium desensitized s
124 ist and [(3)H]azietomidate, amino acids were photolabeled in the ion channel [position M2-20 (alphaGl
125 e alphaM1 and alphaM4 helices, identified by photolabeling in alphaM1 (alphaCys-222/alphaLeu-223); an
129 domain: 1) in the ion channel, identified by photolabeling in the M2 helices of betaVal-261 and delta
130 unit site in the delta subunit helix bundle, photolabeling in the nAChR desensitized state (+agonist)
131 a site within the ion channel, identified by photolabeling in the nAChR desensitized state of amino a
132 and deltaCys-236); (ii) in the ion channel, photolabeling in the nAChR resting, closed channel state
134 es elicited by the activation of efficacious photolabels in vivo with time-resolved proteomics provid
139 or from detergent extracts of bovine cortex, photolabeled it with [(3)H]Ro15-4513, and identified (3)
142 ta)-6-azi-pregnanolone (6-AziP), was used to photolabel membranes from Sf9 cells expressing high-dens
144 f [(3)H]physostigmine- or [(3)H]galanthamine-photolabeled nAChR establish that, in the presence of ag
145 f peptide fragments isolated from [(3)H]CMPI-photolabeled nAChR subunits established photolabeling of
146 idate, an intravenous general anesthetic, we photolabeled nicotinic acetylcholine receptor (nAChR)-ri
147 ng domains in a ligand-gated ion channel, we photolabeled nicotinic acetylcholine receptor (nAChR)-ri
149 imulated ABCB1 ATPase activity and inhibited photolabeling of ABCB1 with [(125)I]-iodoarylazidoprazos
150 erestingly, erlotinib slightly inhibited the photolabeling of ABCB1 with [(125)I]iodoarylazidoprazosi
152 ed as antihypertensive agents, inhibited the photolabeling of ABCG2 with [(125)I]IAAP and [(3)H]azido
157 CMPI-photolabeled nAChR subunits established photolabeling of amino acids contributing to the ACh bin
158 crosequencing, we found propofol-inhibitable photolabeling of amino acids in the beta3-alpha1 subunit
159 ing state), there was tetracaine-inhibitable photolabeling of amino acids in the ion channel at posit
160 ncing established 3alpha5alpha-P inhibitable photolabeling of amino acids near the cytoplasmic end of
162 contrast, within the same site GABA enhances photolabeling of beta3Met-227 in betaM1 by an anesthetic
163 [(3)H]Azietomidate and [(3)H]R-mTFD-MPAB photolabeling of beta3Met-227 in betaM1 established that
164 re was also propofol-inhibitable [(3)H]AziPm photolabeling of beta3Met-227 in betaM1, the amino acid
166 mical modification of this residue abolishes photolabeling of both channels with the ceramide probe.
167 05 in the vestibule of the ion channel, with photolabeling of both residues enhanced in the presence
168 fic, AMP-PCP-enhanced, [(3)H]azidodantrolene photolabeling of both the RyR monomer and a 160 or 172 k
170 imulated GLUT4 translocation, as assessed by photolabeling of cell surface GLUT4 with Bio-LC-ATB-BMPA
171 ition of agonist did not enhance [(125)I]TID photolabeling of deltaIle288 within the deltaM2-M3 loop.
174 [35S]GTPgammaS binding, a decrease in basal photolabeling of G-proteins with azidoanilido-[alpha-32P
176 (A)R-modulating neurosteroids do not inhibit photolabeling of GABA(A)R alpha1Met-236 or betaMet-286 b
179 gamma-alpha subunit interface, identified by photolabeling of gammaMet299 within the gammaM3 helix at
181 ty labeling (BEProFL) approach that utilizes photolabeling of HDAC8 with a probe containing a UV-acti
182 al analyses, radioligand binding assays, and photolabeling of nAChR-rich membranes with [3H]BP to ide
184 P produced time- and concentration-dependent photolabeling of protein bands of approximately 35 and 6
186 hyperspectral visual stimulation as well as photolabeling of RGCs to provide a functional and anatom
187 specifically inhibits [(3)H]azidodantrolene photolabeling of RyR1 and its N-terminal fragment in SR.
191 s not have an effect on the Kd value; and 3) photolabeling of the protein with a cysteine residue in
192 ([(125)I]TID) to compare the state-dependent photolabeling of the Torpedo nAChR before and after puri
194 ersubunit sites, inhibited [(3)H]S-mTFD-MPPB photolabeling of these nAChR intrasubunit binding sites.
198 solated from proteolytic digests established photolabeling of two residues: one within the alphaM1 tr
200 xes, 8-azido-ATP was found to preferentially photolabel one chain of the homodimer, suggesting that t
202 esthetic steroid alphaxalone, which enhanced photolabeling, or DS-2, a delta subunit-selective positi
203 assays of the ATPase activity of P-gp and by photolabeling P-gp with its transport substrate [(125)I]
204 ed His(8)-beta3 subunits identified a single photolabeled peptide, ALLEYAF-6-AziP, in the third trans
205 nity chromatography and reversed-phase HPLC, photolabeled peptides located within or near the phospha
208 oth agents were also effective and selective photolabels, photoincorporating into some, but not all,
210 ytoplasmic end of the M2 ion channel domain, photolabeling positions M2-2, M2-6, and/or M2-9 in each
212 itate a small fraction of the 45- and 40-kDa photolabeled proteins, suggesting that these proteins as
214 termine the sites of cholesterol binding, we photolabeled purified mouse VDAC1 (mVDAC1) with photoact
215 beta (+)/alpha (-) pockets, the barbiturate photolabel R-5-allyl-1-methyl-5-(m-trifluoromethyl-diazi
217 coupled to an alkyne-containing neurosteroid photolabeling reagent and used to identify peptide-stero
218 inding sites directly, a neurosteroid-analog photolabeling reagent, (3alpha,5beta)-6-azi-pregnanolone
219 4 was found to be an exceptionally efficient photolabeling reagent, incorporating into both alpha1 an
221 alent attachment site for Bpa(4)-SP, a small photolabeled receptor fragment was generated by chemical
222 c and chemical fragmentation analysis of the photolabeled receptor mutants established that the sites
224 ltaM2-13') that line the channel lumen (with photolabeling reduced by >90% in the desensitized state)
225 like the parent anesthetic, and identify two photolabeled residues (V954 and E969) in the S6 helix.
227 ometry (MS), we identified three clusters of photolabeled residues representing three distinct neuros
228 le different adduct masses were found on the photolabeled residues, and the molecular identity of eac
230 Cyanogen bromide cleavage of the [125I]IACoc photolabeled sigma-1 receptor followed by radiosequencin
231 ore, after cleaving the specific [(125)I]IAF-photolabeled sigma-1 receptor in guinea pig and rat live
234 table cholesterol analogues and analyzed the photolabeled sites with both top-down mass spectrometry
236 tation of solubilized, [(3)H]azidodantrolene-photolabeled SR protein reveals that the cleaved 160/172
239 19-[3H]BPC-discodermolide), was selected for photolabeling studies because it had the highest extent
244 DsRed-derived variants which we showcase in photolabeling studies, and discuss these data in terms o
248 In this study, we developed an intact cell photolabeling technique that allows the direct visualiza
249 (D-mannose-4-yloxy)-2-propylamine exofacial photolabeling technique, was reduced by approximately 70
253 tinic acetylcholine receptors (nAChRs) and a photolabel that incorporates both at the lipid-protein i
254 cing revealed that R-[(3)H]mTFD-MPAB did not photolabel the etomidate sites at the beta(+)-alpha(-) s
255 table analogs of 1-butanol and 1-octanol, to photolabel the purified Ig1-4 domain of human L1 (hL1 Ig
258 icated that [(3)H]3'-(p-azidobenzamido)Taxol photolabels the N-terminal 31 amino acids of beta-tubuli
259 r of chiral barbiturates that are capable of photolabelling their binding sites on GABAA receptors.
260 was mutated to a glutamine, KK174 no longer photolabeled this residue, but instead labeled the nearb
262 Torpedo californica nAChRs and time-resolved photolabeling to identify the nAChR binding sites occupi
263 atidine in a muscle and a neuronal nAChR, we photolabeled Torpedo alpha(2)betagammadelta and expresse
264 -binding regions on Palpha and Pbeta through photolabel transfer from various Pgamma positions throug
265 were able to investigate this issue using a photolabel transfer strategy that allows for mapping the
266 candidate targets, we used a combination of photolabeling, two-dimensional gel electrophoresis, and
268 on the full ectodomain LFA-1 were probed by photolabeling using photoactivatable isoflurane (azi-iso
269 purified recombinant PfCRT, we analyze AzBCQ photolabeling versus competition with CQ and other drugs
270 Within alpha subunit, >/=95% of specific photolabeling was contained within a 20-kilodalton prote
274 e antagonist, or isoflurane, state-dependent photolabeling was seen in a delta subunit fragment begin
275 inhibitory effects elicited by these MSAs on photolabeling were distinct for beta-tubulin from differ
276 alphaM1 and deltaTyr-228 within deltaM1 were photolabeled, while no labeled amino acids were identifi
278 in GDP-fucose transport and was specifically photolabeled with 8-azidoguanosine-5'-[alpha-(32)P]triph
279 ), opsin and membrane lipids were dominantly photolabeled with [(14)C]halothane, but none of the thre
281 subunits, isolated from nAChR-rich membranes photolabeled with [(3)H]Bz(2)choline, were digested enzy
283 Subunits isolated from nAChR-rich membranes photolabeled with [(3)H]tetracaine were subjected to enz
284 -subunit, isolated from nAChR-rich membranes photolabeled with [3H]dTC, was digested with Staphylococ
285 ovary cells was specifically and efficiently photolabeled with a radioiodinated derivative of Bpa(4)-
286 a-tubulin isotype content, were specifically photolabeled with a tritium-labeled Taxol analog, 2-(m-a
288 ylcholine vesicles and could be specifically photolabeled with P3-(4-azidoanilido)-uridine-5'-[P1-32P
289 To identify this site, PKCdelta C1B was photolabeled with three photo-activable diazirine alcoho
290 vesicles of defined composition and by using photolabeling with 3-trifluoromethyl-3-(m-[125I]iodophen
293 shows greatly decreased activity, abolished photolabeling with [32P]8N3ATP, and no detectable autoin
294 ytochrome c oxidase (CcO) were identified by photolabeling with arylazido-cardiolipin analogues and d
295 rs that combines attributes of high-contrast photolabeling with high-sensitivity Ca(2+) detection in
296 ain of the Torpedo nAChR using time-resolved photolabeling with the hydrophobic probe 3-(trifluoromet
297 and cell surface GLUT4 levels as assessed by photolabeling with the membrane-impermeant reagent 2-N-(
301 or the purified nAChR, the agonist-sensitive photolabeling within the M2 ion channel domain of positi